Acute kidney injury(AKI)is a complex syndrome with an abrupt decrease of kidney function,which is associated with high morbidity and mortality.Sepsis is the common cause of AKI.Mount-ing evidence has demonstrated that long non-coding RNAs(IncRNAs)play critical roles in the development and progression of sepsis-induced AKI.In this study,we aimed to illustrate the func-tion and mechanism of IncRNA SNHG14 in lipopolysaccharide(LPS)-induced AKI.We found that SNHG14 was highly expressed in the plasma of sepsis patients with AKI.SNHG14 inhibited cell proliferation and autophagy and promoted cell apoptosis and inflammatory cytokine production in LPS-stimulated HK-2 cells.Functionally,SNHG14 acted as a competing endogenous RNA(ceRNA)to negatively regulate miR-495-3p expression in HK-2 cells.Furthermore,we identified that HIPK1 is a direct target of miR-495-3p in HK-2 cells.We also revealed that the SNHG14/miR-495-3p/HIPK1 interaction network regulated HK-2 cell proliferation,apoptosis,autophagy,and inflammatory cytokine production upon LPS stimulation.In addition,we demonstrated that the SNHG14/miR-495-3p/HIPK1 interaction network regulated the production of inflammatory cytokines(TNF-α,IL-6,and IL-1p)via modulating NF-κB/p65 signaling in LPS-challenged HK-2 cells.In conclusion,our findings suggested a novel therapeutic axis of SNHG14/miR-495-3p/HIPK1 to treat sepsis-induced AKI.